The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)

By Cheng E.   Cardenas-Freytag L.   Clements J.D.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 38-49

Elsevier

Access to resources Recommend Favorite

Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine

By Lu X.   Clements J.D.   Katz J.M.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1019-1029

Elsevier

Access to resources Recommend Favorite

LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.

By Chong C.   Friberg M.   Clements J.D.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 732-740

Elsevier

Access to resources Recommend Favorite

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant

By Marchetti M.   Rossi M.   Giannelli V.   Giuliani M.M.   Pizza M.   Censini S.   Covacci A.   Massari P.   Pagliaccia C.   Manetti R.   Telford J.L.   Douce G.   Dougan G.   Rappuoli R.   Ghiara P.  

Vaccine, Vol. 16, Iss. 1, 1998-01 ,pp. : 33-37

Elsevier

Access to resources Recommend Favorite

Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine

By Komase K.   Tamura S.-i.   Matsuo K.   Watanabe K.   Hattori N.   Odaka A.   Suzuki Y.   Kurata T.   Aizawa C.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 248-254

Elsevier

Access to resources Recommend Favorite